Human Genetics

, Volume 66, Issue 2–3, pp 147–150 | Cite as

Arylsulfatase A in pseudodeficiency

  • Barbara Herz
  • G. Bach
Original Investigations

Summary

Arylsulfatase A (ASA) is found to be deficient in healthy individuals (pseudo arylsulfatase A deficiency) who usually show in vitro ASA levels in the range of metachromatic leukodystrophy patients. The in vitro properties of ASA in pseudodeficiency were studied in cultured fibroblasts. The residual ASA activity showed apparent Km with the synthetic substrate (2.6mM), pH optimum of activity (pH 5.0), and sensitivity to heat denaturation at 65°C (T1/2, 10 min) similar to those found in controls. To test whether the low in vitro activity is a result of extreme sensitivity to the homogenization procedure, cells were disrupted by five different techniques, including rapid freezing and thawing, hand homogenization, ultrasonication, mild osmotic shock, and nitrogen cavitation; all yielded similar ASA ratio of the pseudodeficient to control. The use of antiproteases phenylmethylsulfonyl fluoride and leupeptin did not affect the residual ASA activity in the pseudodeficient line. These results imply that the ASA that is formed in this condition has properties similar to those of the normal hydrolase, so that even if it is synthesized in lower amounts, it is still sufficient to promote normal catabolism of sulfatide. Screening for ASA activity in lymphocyte extracts of a random sample of 250 individuals revealed 7 individuals with enzyme level in the MLD heterozygote range or lower. These individuals apparently represent homozygosity for pseudodeficiency (pd/pd). This implies that the frequency of the pseudodeficient allele is about 15% in the general population, leading to polymorphism of the ASA.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bach G, Liebman A (1979) Intracellular localization of exogenous β-glucuronidase in cultured skin fibroblasts. Eur J Biochem 96:613–619Google Scholar
  2. Bach G, Neufeld EF (1983) Synthesis and maturation of crossreactive glycoprotein in fibroblasts deficient in aryl sulfatase A activity. Biochem Biophys Res Commun 112:198–205Google Scholar
  3. Bach G, Friedman R, Weissmann B, Neufeld EF (1972) The defect in the Hurler and Scheie syndromes: deficiency of α-L-iduronidase. Proc Nat Acad Sci USA 69:2048–2051Google Scholar
  4. Bach G, Zeigler M, Kohn G, Cohen MM (1977) Mucopolysaccharide accumulation in cultured skin fibroblasts derived from patients with mucolipidoses IV. Am J Hum Genet 29:610–618Google Scholar
  5. Baum H, Dodgson KS, Spencer B (1959) The assay of aryl sulfatase A and B in human urine. Clin Chim Acta 4:453–455Google Scholar
  6. Bøyum A (1968) A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. Scand J Clin Invest 93:265–275Google Scholar
  7. Eliahu R, Sekeles E, Cohen R, Bach G (1981) The correction of Hunter fibroblasts by exogenous iduronate sulfatase: Biochemical and ultrastructural studies. Am J Hum Genet 33:576–583Google Scholar
  8. Fluharty AL, Meek WE, Kihara H (1983) Pseudo arylsulfatase A deficiency: Evidence for a structurally altered enzyme. Biochem Biophys Res Commun 112:191–197Google Scholar
  9. Kihara H (1982) Genetic heterogeneity in metachromatic leukodystrophy. Am J Hum Genet 34:171–181Google Scholar
  10. Kihara H, Ho C-K, Fluharty AL, Tsay KK, Hartlage DL (1980) Prenatal diagnosis of metachromatic leukodystrophy in a family with pseudo aryl sulfatase A deficiency by the cerebroside sulfate loading test. Pediatr Res 14:224–227Google Scholar
  11. Kihara H, Fluharty AL, Tsay KK, Bachman RP, Stephens JD, Ng WG (1983) Prenatal diagnosis of pseudo arylsulfatase A deficiency. Prenat Diagn 3:29–34Google Scholar
  12. Kolodny EH, Moser HW (1982) Metachromatic leukodystrophy. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease, 5th edn. McGraw Hill, New York, pp 881–905Google Scholar
  13. Kudoh T, Sattler M, Malmstrom J, Bitter MA, Wenger DA (1981) Metabolism of fatty acid labeled cerebroside sulfate in cultured cells from controls and metachromatic leukodystrophy. J Lab Clin Med 5:504–714Google Scholar
  14. Lineweaver H, Burk D (1934) The determination of enzyme dissociation constants. J Am Chem Soc 56:658–666Google Scholar
  15. Lowry O, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with folin phenol reagent. J Biol Chem 93:265–275Google Scholar
  16. Porter MT, Fluharty AL, Trammel J, Kihara HA (1971) Correlation of intracellular cerebroside sulfate sulfatase activity in fibroblasts with latency in metachromatic leukodystrophy. Biochem Biophys Res Commun 44:660–666Google Scholar
  17. Rome LH, Garvin JA, Allietta MM, Neufeld EF (1979) Two species of lysosomal organelles in cultured human fibroblasts. 17:143–154Google Scholar
  18. Schaap T, Zlotogora J, Elian E, Barak Y, Bach G (1981) The genetics of the aryl sulfatase A locus. Am J Hum Genet 33:531–539Google Scholar
  19. Zlotogora J, Bach G, Barak Y, Elian E (1980) Metachromatic leukodystrophy in the Habbanite Jews: High frequency in a genetic isolate and screening for heterozygotes. Am J Hum Genet 32:663–669Google Scholar
  20. Zlotogora J, Bach G (1983) Deficiency of lysosomal hydrolases in apparently healthy individuals. Am J Med Genet 14:73–80Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • Barbara Herz
    • 1
  • G. Bach
    • 1
  1. 1.Department of Human GeneticsHadassah Hebrew University HospitalJerusalemIsrael

Personalised recommendations